Therapy News and Research

RSS

AI-enabled device detects if targeted chemotherapy is working

A new portable device that utilizes artificial intelligence (AI) and biosensors can rapidly detect if cancer cells thrive after chemotherapy treatment.

17 Jul 2019

Stroke should be treated 15 minutes earlier to save lives, study suggests

A team of researchers at the David Geffen School of Medicine in the University of California, Los Angeles (UCLA) wanted to determine the association between time to treatment with Endovascular Reperfusion Therapy and outcomes in patients with acute ischemic stroke.

17 Jul 2019

Novel vaccine against bee sting allergy successfully tested

A recently completed trial on a bee sting vaccine containing a novel adjuvant called Advax to increase its efficacy has raised hopes that severe allergic reactions, sometimes fatal, to bee venom in allergic people could soon be a thing of the past. The vaccine was designed to neutralize the venom of the European honeybee.

17 Jul 2019

Sleep quality and fatigue among women with premature ovarian insufficiency

There have been studies and anecdotal reports about worsening of sleep quality and increasing fatigue among women who are near menopause or have reached menopause.

16 Jul 2019

New therapy shows promise in preventing brain damage after traumatic brain injury

Nearly three million people in the United States experience traumatic brain injury (TBI) every year, and there are no pre or post-TBI treatment options available. Now, a new novel therapy shows promise in preventing brain damage after traumatic brain injury.

16 Jul 2019

Antioxidant precursor molecule could improve dopamine levels in Parkinson's patients

N-acetylcysteine (NAC) is a naturally occurring molecule that replenishes one of the body's antioxidants and now shows potential benefit as part of a standard course of treatment for patients with Parkinson's disease, according to a study published in the journal, Clinical Pharmacology & Therapeutics.

16 Jul 2019

Gene modulation goes wireless hacking the "boss gene"

Researchers from the University at Buffalo have successfully used technology to wirelessly tweak the functioning of a gene FGFR1. This gene is vital in the growth of embryos into adults. Their experiments were successful in the lab grown brain tissues and shows potential in therapeutics.

16 Jul 2019

Transgender and non-binary individuals more likely to display autistic traits, study finds

New research indicates that transgender and non-binary individuals are significantly more likely to have autism or display autistic traits than the wider population - a finding that has important implications for gender confirmation treatments.

16 Jul 2019

New method spots rare immune cells reactive against cancer

Researchers from the Garvan Institute of Medical Research have developed a new method to spot rare immune cells that are reactive against cancer cells, from within a patient's own immune system.

16 Jul 2019

Anorexia may be as much a metabolic disorder as it is a psychiatric one, say scientists

A study has found that anorexia nervosa may have a metabolic component that makes some patients lose weight more easily and be harder to treat.

16 Jul 2019

MGH researchers identify potential markers of lung cancer

By examining both blood samples and tumor tissues from patients with non-small-cell lung cancer, investigators at Massachusetts General Hospital have identified markers that can distinguish between major subtypes of lung cancer and can accurately identify lung cancer stage.

16 Jul 2019

Loose double-stranded RNA molecules spur skin rejuvenation

Want to smooth out your wrinkles, erase scars and sunspots, and look years younger? Millions of Americans a year turn to lasers and prescription drugs to rejuvenate their skin, but exactly how that rejuvenation works has never been fully explained.

From Johns Hopkins Medicine 16 Jul 2019

UMass Amherst scientist receives $792,000 grant to advance cancer immunotherapy research

Biomedical engineer Ashish Kulkarni, assistant professor of chemical engineering at the University of Massachusetts Amherst, has been awarded a four-year, $792,000 grant from the American Cancer Society to advance his interdisciplinary lab's promising cancer immunotherapy research.

16 Jul 2019

Lipid-lowering drugs are underutilized for preventing atherosclerotic cardiovascular disease

Statins, the most commonly used effective lipid-lowering drugs, are significantly underutilized to treat lipid abnormalities in patients with and at risk for atherosclerotic cardiovascular disease, according to a retrospective study of more than 280,000 patients in Alberta, Canada.

16 Jul 2019

Therapy News and Research

AI-enabled device detects if targeted chemotherapy is working

Stroke should be treated 15 minutes earlier to save lives, study suggests

Novel vaccine against bee sting allergy successfully tested

Sleep quality and fatigue among women with premature ovarian insufficiency

New therapy shows promise in preventing brain damage after traumatic brain injury

Antioxidant precursor molecule could improve dopamine levels in Parkinson's patients

Gene modulation goes wireless hacking the "boss gene"

Transgender and non-binary individuals more likely to display autistic traits, study finds

New method spots rare immune cells reactive against cancer

Anorexia may be as much a metabolic disorder as it is a psychiatric one, say scientists

MGH researchers identify potential markers of lung cancer

Loose double-stranded RNA molecules spur skin rejuvenation

UMass Amherst scientist receives $792,000 grant to advance cancer immunotherapy research

Lipid-lowering drugs are underutilized for preventing atherosclerotic cardiovascular disease

HIV therapy leaves unrepaired holes in the immune system's wall of defense

HIV DNA persists in spinal fluid despite treatment, linked to cognitive impairment

HIV persists in spinal fluid even after long-term treatment and is linked to cognitive deficits

Cannabis-based medication helps tackle dependency on cannabis

Patients with HIV DNA in cerebrospinal fluid have high risk of experiencing cognitive deficits

WHO's 'Treat All' HIV recommendation widely adopted globally

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News